Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lovejoy

Showing results (11-20 of 71) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|July 2, 2011
Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancerZaklina Kovacevic, Sherin Chikhani, David B Lovejoy, et al.
Protein Science : a Publication of the Protein Society|August 1, 1992
Crystallization of proton channel peptidesB Lovejoy, K S Akerfeldt, W F DeGrado, et al.
Hemoglobin|March 17, 2006
PCTH: a novel orally active chelator for the treatment of iron overload diseaseDavid B Lovejoy, Danuta Kalinowski, Paul V Bernhardt, et al.
Current Medicinal Chemistry|May 4, 2017
Major Developments in the Design of Inhibitors along the Kynurenine PathwayKelly R Jacobs, Gloria Castellano-Gonzalez, Gilles J Guillemin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311Timothy B Chaston, David B Lovejoy, Ralph N Watts, et al.
Journal of Inorganic Biochemistry|August 20, 2010
The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: an EPR studyPatric J Jansson, Clare L Hawkins, David B Lovejoy, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 8, 2003
Four cytotoxic N4-substituted thiosemicarbazones derived from 2-hydroxynaphthalene-1-carboxaldehydePaul V Bernhardt, Lorraine M Caldwell, David B Lovejoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Chelators at the cancer coalface: desferrioxamine to Triapine and beyondYu Yu, Jacky Wong, David B Lovejoy, et al.
The International Journal of Biochemistry & Cell Biology|December 23, 2003
Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasitesAsikiya Walcourt, Mark Loyevsky, David B Lovejoy, et al.
Biochemistry|July 12, 1994
Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itselfB Lovejoy, A M Hassell, M A Luther, et al.
Pageof 8

Showing results (11-20 of 71) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|July 2, 2011
Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancerZaklina Kovacevic, Sherin Chikhani, David B Lovejoy, et al.
Protein Science : a Publication of the Protein Society|August 1, 1992
Crystallization of proton channel peptidesB Lovejoy, K S Akerfeldt, W F DeGrado, et al.
Hemoglobin|March 17, 2006
PCTH: a novel orally active chelator for the treatment of iron overload diseaseDavid B Lovejoy, Danuta Kalinowski, Paul V Bernhardt, et al.
Current Medicinal Chemistry|May 4, 2017
Major Developments in the Design of Inhibitors along the Kynurenine PathwayKelly R Jacobs, Gloria Castellano-Gonzalez, Gilles J Guillemin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311Timothy B Chaston, David B Lovejoy, Ralph N Watts, et al.
Journal of Inorganic Biochemistry|August 20, 2010
The iron complex of Dp44mT is redox-active and induces hydroxyl radical formation: an EPR studyPatric J Jansson, Clare L Hawkins, David B Lovejoy, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|November 8, 2003
Four cytotoxic N4-substituted thiosemicarbazones derived from 2-hydroxynaphthalene-1-carboxaldehydePaul V Bernhardt, Lorraine M Caldwell, David B Lovejoy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
Chelators at the cancer coalface: desferrioxamine to Triapine and beyondYu Yu, Jacky Wong, David B Lovejoy, et al.
The International Journal of Biochemistry & Cell Biology|December 23, 2003
Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasitesAsikiya Walcourt, Mark Loyevsky, David B Lovejoy, et al.
Biochemistry|July 12, 1994
Crystal structures of recombinant 19-kDa human fibroblast collagenase complexed to itselfB Lovejoy, A M Hassell, M A Luther, et al.
Pageof 8